The Effects of Audio-Based Therapy on Anxiety in Psoriasis (NCT07390487)
🩺 Plain-English Summary (8th-Grade Level)
Anxiety in psoriasis is associated with impaired quality of life, and the prevalence of anxiety symptoms in psoriatic populations is approximately 34% and anxiety disorders up to 16%. Many experts recommend routine screening, referral, and interventions for anxiety in psoriasis; however, many barriers inhibit access to mental health resources and proper management. To our knowledge, there is a lack of easily accessible interventions that manage anxiety. Audio-based therapy offers convenient and effective interventions that show reduced anxiety in published, randomized studies and is a promising management for psoriasis patients. This study will evaluate the effects of audio therapy in patients with psoriasis and measure changes in overall symptoms.
Who can join: Review the eligibility criteria below.
Location: Liao Lab at UCSF — San Francisco, California
Age range: 18 Years
🧪 Interventions in This Study
- Music Therapy (BEHAVIORAL)
- Pink Noise (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Liao Lab at UCSF — San Francisco, California
📞 Contact the Study Coordinator
Phone: (415) 944-7618
Email: amelie.spangenberg@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Psoriasis (PsO)
- A Clinical Trial of Antiplatelets in Psoriasis — New York, New York
- A Study to Assess Deucravacitinib Safety in Pregnancy — La Jolla, California
- Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis — Toronto, Ontario
- Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada — Burlington, Ontario
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis — Monterrey, N.L.
Explore by condition: All Psoriasis (PsO) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.